A Study to Learn About Lorlatinib in Patients With Non-Small Cell Lung Cancer Which Could Not Be Controlled
Clinical trial NCT06282991 · COMPLETED
Trial details
- NCT number
- NCT06282991
- Sponsor
- Pfizer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-07-22
- Primary completion
- 2021-01-18
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.